This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Diarrhea-predominant Irritable Bowel Syndrome
and you are a woman who is
between 20 and 64
years old
Phase
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

To evaluate the efficacy and safety of YM060 once daily for female patients with diarrhea-predominant irritable bowel syndrome (D-IBS) for a long-term period (up to 52 weeks).

Provided treatments

  • Drug: YM060
Tris trial is registered with FDA with number: NCT01736423. The sponsor of the trial is Astellas Pharma Inc and it is looking for 151 volunteers for the current phase.
Official trial title:
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome